Cargando…
Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis
OBJECTIVES: Soluble urokinase plasminogen activated receptor (suPAR) is a biomarker that may predict the occurrence of focal segmental glomerulosclerosis (FSGS); however, there is still controversy about whether suPAR can predict FSGS. In this study, we performed a systematic evaluation and meta-ana...
Autores principales: | Shuai, Tiankui, Pei Jing, Yan, Huang, Qiangru, Xiong, Huaiyu, Liu, Jingjing, Zhu, Lei, Yang, Kehu, Jian, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797292/ https://www.ncbi.nlm.nih.gov/pubmed/31594897 http://dx.doi.org/10.1136/bmjopen-2019-031812 |
Ejemplares similares
-
Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Shuai, Tiankui, et al.
Publicado: (2019) -
The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997) -
Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method
por: Winnicki, Wolfgang, et al.
Publicado: (2019) -
Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2014) -
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
por: Kronbichler, Andreas, et al.
Publicado: (2016)